Chronic kidney disease is one of the top global health challenges. This challenge is compounded by the fact that many patients are unaware they have CKD. The first step in addressing this issue is to create awareness of CKD and the benefits of early screening. Prof. Nancy Brunzel led a discussion in 2021, hosted by AACC, addressing this challenge in light of the COVID-19 pandemic. Prof. Brunzel joins with Dr. Keiichi Sumida to discuss this global problem, particularly among underserved populations in both developed and developing countries. Dr. Sumida will share his research to raise awareness of the importance of chronic kidney disease screening, which can be performed by measuring urine albumin-to-creatinine ratio. Dr. Sumida will also discuss his research in determining urine albumin-to-creatinine ratio from urine protein results, which can be used in resource-limited communities.
Keiichi Sumida, MD, MPH, PhD
Assistant Professor, Division of Nephrology, Department of Medicine University of Tennessee Health Science Center Memphis, TN
Nancy Brunzel, MS, MLS (ASCP) CM
Assistant Professor (Retired) University of Minnesota
Key learning objectives
- Understand the importance of albumin-to-creatinine ratio in chronic kidney disease.
- Understand the difference between urine dipstick protein and urine albumin-to-creatinine ratio.
- Understand how predicted ACR may be useful and informative.
Who should attend?
Point of Care Coordinators, nurses (especially nephrology nurses and technicians), physicians, nephrologists, urologists, endocrinologists, clinicians, patients, providers, researchers